Cargando…

Regulation of SCN3B/scn3b by Interleukin 2 (IL-2): IL-2 modulates SCN3B/scn3b transcript expression and increases sodium current in myocardial cells

BACKGROUND: In the initiation and maintenance of arrhythmia, inflammatory processes play an important role. IL-2 is a pro-inflammatory factor which is associated with the morbidity of arrhythmias, however, how IL-2 affects the cardiac electrophysiology is still unknown. METHODS: In the present study...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Yuanyuan, Sun, Qiaobing, Zeng, Zhipeng, Li, Qianqian, Zhou, Shiyuan, Zhou, Mengchen, Xue, Yumei, Cheng, Xiang, Xia, Yunlong, Wang, Qing, Tu, Xin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4700781/ https://www.ncbi.nlm.nih.gov/pubmed/26728597 http://dx.doi.org/10.1186/s12872-015-0179-x

Ejemplares similares

Effects of GRM4, SCN2A and SCN3B polymorphisms on antiepileptic drugs responsiveness and epilepsy susceptibility
por: AL-Eitan, Laith N., et al.
Publicado: (2019)

SCN1B and SCN2B gene variants analysis in dravet syndrome patients: Analysis of 22 cases
por: Gong, Jiao-E., et al.
Publicado: (2019)

miR-190a-5p Partially Represses the Abnormal Electrical Activity of SCN3B in Cardiac Arrhythmias by Downregulation of IL-2
por: Li, Qianqian, et al.
Publicado: (2022)

Data on mutations and Clinical features in SCN1A or SCN2A gene
por: Kong, Yanting, et al.
Publicado: (2018)

Association of SCN1A, SCN2A, and UGT2B7 Polymorphisms with Responsiveness to Valproic Acid in the Treatment of Epilepsy
por: Lu, Yuan, et al.
Publicado: (2020)

Delayed maturation of GABAergic signaling in the Scn1a and Scn1b mouse models of Dravet Syndrome
por: Yuan, Yukun, et al.
Publicado: (2019)

Scn3b knockout mice exhibit abnormal ventricular electrophysiological properties
por: Hakim, Parvez, et al.
Publicado: (2008)

SCN1B gene variants in Brugada Syndrome: a study of 145 SCN5A-negative patients
por: Ricci, Maria Teresa, et al.
Publicado: (2014)

Painful and painless mutations of SCN9A and SCN11A voltage-gated sodium channels
por: Baker, Mark D., et al.
Publicado: (2020)

Association Between SCN1A rs2298771, SCN1A rs10188577, SCN2A rs17183814, and SCN2A rs2304016 Polymorphisms and Responsiveness to Antiepileptic Drugs: A Meta-Analysis
por: Li, Mengmeng, et al.
Publicado: (2021)

Heterozygous deletion of SCN2A and SCN3A in a patient with autism spectrum disorder and Tourette syndrome: a case report
por: Nickel, Kathrin, et al.
Publicado: (2018)

Characterization of maturation of neuronal voltage-gated sodium channels SCN1A and SCN8A in rat myocardium
por: Krause, Ulrich, et al.
Publicado: (2015)

Scn3b knockout mice exhibit abnormal sino-atrial and cardiac conduction properties
por: Hakim, P, et al.
Publicado: (2010)

Novel presentation of SCN5A nonsense mutation as SCN5A overlap syndrome
por: Ahn, Hyo-Jeong, et al.
Publicado: (2021)

Crystal structure of Ag(2)(μ-SCN)(2)(NH(3))(4)
por: Müller, Thomas G., et al.
Publicado: (2016)

Na(+) current properties in islet α- and β-cells reflect cell-specific Scn3a and Scn9a expression
por: Zhang, Quan, et al.
Publicado: (2014)

Scn1b deletion in adult mice results in seizures and SUDEP
por: O'Malley, Heather A., et al.
Publicado: (2019)

SCN1B‐linked early infantile developmental and epileptic encephalopathy
por: Aeby, Alec, et al.
Publicado: (2019)

SCN1A and SCN1B gene polymorphisms and their association with plasma concentrations of carbamazepine and carbamazepine 10, 11 epoxide in Iranian epileptic patients
por: Namazi, Soha, et al.
Publicado: (2015)

Crystal structure of K[Hg(SCN)(3)] – a redetermination
por: Weil, Matthias, et al.
Publicado: (2014)

Neuropeptide Signaling Differentially Affects Phase Maintenance and Rhythm Generation in SCN and Extra-SCN Circadian Oscillators
por: Hughes, Alun T. L., et al.
Publicado: (2011)

Influence of common SCN1A promoter variants on the severity of SCN1A‐related phenotypes
por: de Lange, Iris M., et al.
Publicado: (2019)

Reduction of Kcnt1 is therapeutic in mouse models of SCN1A and SCN8A epilepsy
por: Hill, Sophie F., et al.
Publicado: (2023)

Two Novel Functional Mutations in Promoter Region of SCN3B Gene Associated with Atrial Fibrillation
por: Lin, Liyan, et al.
Publicado: (2022)

Scn8a Antisense Oligonucleotide Is Protective in Mouse Models of SCN8A Encephalopathy and Dravet Syndrome
por: Lenk, Guy M., et al.
Publicado: (2020)

An enhancer cluster controls gene activity and topology of the SCN5A-SCN10A locus in vivo
por: Man, Joyce C. K., et al.
Publicado: (2019)

De novo mutations of SCN1A are responsible for arthrogryposis broadening the SCN1A-related phenotypes
por: Jaber, Dana, et al.
Publicado: (2021)

Pathogenic in-Frame Variants in SCN8A: Expanding the Genetic Landscape of SCN8A-Associated Disease
por: Wong, Jennifer C., et al.
Publicado: (2021)

Commonalities and distinctions between two neurodevelopmental disorder subtypes associated with SCN2A and SCN8A variants and literature review
por: Mangano, Giuseppe Donato, et al.
Publicado: (2022)

Embryonic type Na(+) channel β-subunit, SCN3B masks the disease phenotype of Brugada syndrome
por: Okata, Shinichiro, et al.
Publicado: (2016)

SCN1Bβ mutations that affect their association with Kv4.3 underlie early repolarization syndrome
por: Yao, Hao, et al.
Publicado: (2018)

Crystal structure of [NiHg(SCN)(4)(CH(3)OH)(2)](n)
por: Weil, Matthias, et al.
Publicado: (2014)

The possible effect of SCN1A and SCN2A genetic variants on carbamazepine response among Khyber Pakhtunkhwa epileptic patients, Pakistan
por: Nazish, Haleema Rehana, et al.
Publicado: (2018)

Spectrum of SCN8A-Related Epilepsy
por: Morgan, Lindsey A., et al.
Publicado: (2015)

Redetermination of the crystal structure of K(2)Hg(SCN)(4)
por: Bandemehr, Jascha, et al.
Publicado: (2017)

Physicochemical Evaluation of Lyophilized Formulation of p-SCN-Bn-DOTA- and p-SCN-Bn-DTPA-rituximab for NHL Radio Immunotherapy
por: Ackova, Darinka Gjorgieva, et al.
Publicado: (2016)

A Complex Genomic Rearrangement Resulting in Loss of Function of SCN1A and SCN2A in a Patient with Severe Developmental and Epileptic Encephalopathy
por: Orlando, Valeria, et al.
Publicado: (2022)

ERK/MAPK Is Essential for Endogenous Neuroprotection in SCN2.2 Cells
por: Karmarkar, Sumedha W., et al.
Publicado: (2011)

Bidirectional Regulation of AdpA(ch) in Controlling the Expression of scnRI and scnRII in the Natamycin Biosynthesis of Streptomyces chattanoogensis L10
por: Yu, Pin, et al.
Publicado: (2018)

Meta-Analysis of Risk Stratification of SCN5A With Brugada Syndrome: Is SCN5A Always a Marker of Low Risk?
por: Yang, Yihan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_uop5hu9oda20s5kkdi9mfhn1ru